Mark Christopher Capone is President at MYRIAD GENETICS INC (MYGN). They have made 12 open-market trades across 2 companies since 2007, most recently 2026-08-15.
CIK 0001352413
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $524K since 2016, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MYGN | 522,216 | $2.1M |
| MLAB | 6,213 | $790K |
| SERA | 42,404 | $87K |
| DMTK | 82,054 | $8K |
| Total | $3.0M |
Shares reported on the most recent Form 4, priced at the 2026-08-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MLAB | BUY | 2026-03-10 | 2026-03-10 | $76.35 | $99K | +4.9% | +21.7% | +41.5% |
| MYGN | SELL | 2019-08-01 | 2019-08-02 | $44.00 | $6.0M | -43.6% | -47.8% | -25.6% |
| MYGN | SELL | 2018-07-11 | 2018-07-13 | $41.00 | $3.3M | +2.6% | -1.2% | +2.9% |
| MYGN | SELL | 2018-05-30 | 2018-06-01 | $38.00 | $3.4M | -1.2% | -4.2% | +25.9% |
| MYGN | BUY | 2016-08-19 | 2016-08-19 | $21.24 | $425K | -4.3% | -1.9% | -19.3% |
| MYGN | SELL | 2014-02-25 | 2014-02-25 | $37.83 | $3.6M | -0.5% | +0.9% | +0.9% |
| MYGN | SELL | 2014-02-10 | 2014-02-10 | $32.07 | $2.8M | -0.5% | +0.9% | +0.9% |
| MYGN | SELL | 2013-05-16 | 2013-05-17 | $33.23 | $2.7M | -0.5% | +0.9% | +0.9% |
| MYGN | SELL | 2012-11-20 | 2012-11-21 | $30.41 | $1.1M | -0.5% | +0.9% | +0.9% |
| MYGN | SELL | 2012-11-12 | 2012-11-13 | $29.91 | $1.9M | -0.5% | +0.9% | +0.9% |
| MYGN | SELL · 10b5-1 | 2012-11-06 | 2012-11-08 | $28.75 | $776K | -0.5% | +0.9% | +0.9% |
| MYGN | SELL · 10b5-1 | 2012-09-10 | 2012-09-12 | $27.00 | $535K | -0.5% | +0.9% | +0.9% |
| MYGN | SELL · 10b5-1 | 2012-05-02 | 2012-05-04 | $27.00 | $115K | -0.5% | +0.9% | +0.9% |
| MYGN | SELL · 10b5-1 | 2009-04-06 | 2009-04-07 | $43.07 | $1.6M | -0.5% | +0.9% | +0.9% |
| MYGN | SELL | 2009-02-09 | 2009-02-11 | $85.40 | $1.9M | -0.5% | +0.9% | +0.9% |
| MYGN | SELL | 2008-08-29 | 2008-09-03 | $67.93 | $1.2M | -0.5% | +0.9% | +0.9% |
| MYGN | SELL · 10b5-1 | 2007-08-07 | 2007-08-09 | $43.01 | $205K | -0.5% | +0.9% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.